Jung, S.-W.; Lim, S.H.; Jeon, J.J.; Heo, Y.-W.; Choi, M.S.; Hong, S.-P.
Comparison of the Efficacy and Safety of Biologics (Secukinumab, Ustekinumab, and Guselkumab) for the Treatment of Moderate-to-Severe Psoriasis: Real-World Data from a Single Korean Center. Biomedicines 2022, 10, 1058.
https://doi.org/10.3390/biomedicines10051058
AMA Style
Jung S-W, Lim SH, Jeon JJ, Heo Y-W, Choi MS, Hong S-P.
Comparison of the Efficacy and Safety of Biologics (Secukinumab, Ustekinumab, and Guselkumab) for the Treatment of Moderate-to-Severe Psoriasis: Real-World Data from a Single Korean Center. Biomedicines. 2022; 10(5):1058.
https://doi.org/10.3390/biomedicines10051058
Chicago/Turabian Style
Jung, Seung-Won, Sung Ha Lim, Jae Joon Jeon, Yeon-Woo Heo, Mi Soo Choi, and Seung-Phil Hong.
2022. "Comparison of the Efficacy and Safety of Biologics (Secukinumab, Ustekinumab, and Guselkumab) for the Treatment of Moderate-to-Severe Psoriasis: Real-World Data from a Single Korean Center" Biomedicines 10, no. 5: 1058.
https://doi.org/10.3390/biomedicines10051058
APA Style
Jung, S.-W., Lim, S. H., Jeon, J. J., Heo, Y.-W., Choi, M. S., & Hong, S.-P.
(2022). Comparison of the Efficacy and Safety of Biologics (Secukinumab, Ustekinumab, and Guselkumab) for the Treatment of Moderate-to-Severe Psoriasis: Real-World Data from a Single Korean Center. Biomedicines, 10(5), 1058.
https://doi.org/10.3390/biomedicines10051058
